Volume 5, Issue 2 (7-2007)                   IJRM 2007, 5(2): 1-6 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sheikhha M H, Kalantar S M, Ghasemi N. Genetics of polycystic ovary syndrome. IJRM 2007; 5 (2) :1-6
URL: http://ijrm.ir/article-1-64-en.html
Genetics of polycystic ovary syndrome
Mohammad Hasan Sheikhha1 , Seyed Mehdi Kalantar * 2, Nasrin Ghasemi1
1- Yazd Clinical and Research Center for Infertility, Shahid Sadughi University of Medical Sciences, Yazd, Iran
2- Yazd Clinical and Research Center for Infertility, Shahid Sadughi University of Medical Sciences, Yazd, Iran , smkalantar@yahoo.com
Abstract:   (2787 Views)
   Polycystic ovary syndrome (PCOS) is a genetically based disorder which reflects multiple potential aetiologies and variable clinical presentations. It is clearly a heterogeneous syndrome, and current proposed diagnostic criteria include a number of disorders with similar phenotypes but radically different aetiologies. The lack of well-defined diagnostic criteria makes identification of PCOS confusing to many clinicians and seriously delayed the clarification of its genetics, aetiology, clinical associations and assessment of treatment. There is no universally accepted clinical definition for PCOS. In this review the genetic causes and diagnosis criteria of PCOS will be discussed.
Keywords: PCOS, Heterogeneous syndrome, Genetics
Full-Text [PDF 53 kb]   (860 Downloads) |   |   Full-Text (HTML)  (303 Views)  
Type of Study: Original Article |
References
1. Legro RS, Driscoll D. Strauss 3rd JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998; 95: 14956-14960. [DOI:10.1073/pnas.95.25.14956]
2. Gonzalez A, Abril E, Roca A, Aragón MJ, Figueroa M J, Velarde P, et al. Specific CAPN10 Gene Haplotypes Influence the Clinical Profile of Polycystic Ovary Patients. Jo Clin End Met 2003; 88: 5529-5536. [DOI:10.1210/jc.2003-030322]
3. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the south-eastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082. [DOI:10.1210/jcem.83.9.5090]
4. Farah L, Lazenby AJ, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 1999; 44: 870-874.
5. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmarnn BL, Mann K, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005; 37: 438-444. [DOI:10.1055/s-2005-870236]
6. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181. [DOI:10.1016/S0002-9378(15)30642-6]
7. Balen AH, Dunger D. Pubertal maturation of the internal genitalia. Ultrasound Obstet Gynecol 1995; 6: 164-165. [DOI:10.1046/j.1469-0705.1995.06030164.x]
8. Elting MW, Korsen TJM, Rekers-Mombarg LTM, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000; 15: 24-28. [DOI:10.1093/humrep/15.1.24]
9. Zawadzki JA, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR. (eds), Polycystic Ovary Syndrome. Blackwell Scientific, Boston, 1992; 377-384.
10. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 2006; 61: 125-135. [DOI:10.1097/01.ogx.0000197817.93201.04]
11. Legro RS. Diagnostic criteria in polycystic ovary syndrome. Semin Reprod Med 2003; 21: 267-275. [DOI:10.1055/s-2003-43304]
12. Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999; 84: 38-43. [DOI:10.1210/jcem.84.1.5382]
13. Crosignani PG, Nicolosi AE. Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update 2001; 7: 3-7. [DOI:10.1093/humupd/7.1.3]
14. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000; 26: 151-157. [DOI:10.1038/79866]
15. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 1993; 38: 653-658. [DOI:10.1111/j.1365-2265.1993.tb02150.x]
16. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002; 78: 569-576. [DOI:10.1016/S0015-0282(02)03275-2]
17. Diamanti-Kandarakis E, Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 2005; 11: 631-643. [DOI:10.1093/humupd/dmi025]
18. Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 161-165. [DOI:10.1210/jcem.87.1.8137]
19. Meyer MF, Gerresheim F, Pfeiffer A, Epplen JT, Schatz H. Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11. Exp Clin Endocrinol Diabetes 2000; 108: 519-23. [DOI:10.1055/s-2000-11023]
20. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 1998; 53: 217-256.
21. Gharani N, Waterworth DM, Williamson R, Franks S. Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 4174-4180. [DOI:10.1210/jcem.81.11.8923880]
22. Gharani N, Waterworth D, Batty S, White D, Gilling-Smith C, Conway G, et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997; 3: 397-402. [DOI:10.1093/hmg/6.3.397]
23. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999; 96: 8573-8578. [DOI:10.1073/pnas.96.15.8573]
24. SanMillan JL, Sancho J, Calvo RM, Escobar-Morreale HF. Role of the pentanucleotide (TTTTA)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 2001; 75: 797-802. [DOI:10.1016/S0015-0282(01)01677-6]
25. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 2003; 278: 26380-26390. [DOI:10.1074/jbc.M300688200]
26. Witchel SF, Aston CE. The role of heterozygosity for cyp21 in the polycystic ovary syndrome. J Pediatr Endocrinol Metab 2000; 13 Suppl 5: 1315-1317.
27. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, et al. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 2001; 86: 446-449. [DOI:10.1210/jcem.86.1.7274]
28. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165-169. [DOI:10.1097/00006254-199906000-00019]
29. Pfeifer SM. Polycystic ovary syndrome in adolescent girls. Semin Pediatr Surg 2005; 14: 111-117. [DOI:10.1053/j.sempedsurg.2005.01.007]
30. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47. [DOI:10.1093/humrep/deh098]
31. Pigny P, Jonard S, Robert Y, Dewailly D. Serum Anti-Mullerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2005; 10: 2005-2076.
32. Kimura I, Togashi K, kawakami S, Nakano Y, Takakura K, Mori T, et al. Polycystic ovaries implications of diagnosis with MR imaging. Radilogy 1996; 201: 549. [DOI:10.1148/radiology.201.2.8888256]
33. Chakrabarty S, Miller BT, Collins TJ, Nagamani M. Ovarian dysfunction in peripubertal hyperinsulinemia. J Soc Gynecol Investig 2006; 13: 122-129. [DOI:10.1016/j.jsgi.2005.11.005]
34. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861. [DOI:10.1056/NEJM199509283331307]
35. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505-513. [DOI:10.1016/S0015-0282(16)54892-4]
36. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297: 1024-1026. [DOI:10.1136/bmj.297.6655.1024]
37. Balen AH, Tan SL, McDougall J, Jacobs HS. Miscarriage rates following IVF are increased in women with PCO and reduced pituitary desisitization with buserelin. Hum Reprod 1993; 8: 959-964. [DOI:10.1093/oxfordjournals.humrep.a138174]
38. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 1989; 31: 87-120. [DOI:10.1111/j.1365-2265.1989.tb00457.x]
39. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989; 30: 459-470. [DOI:10.1111/j.1365-2265.1989.tb00446.x]
40. Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2004; 2: 13-27. [DOI:10.3121/cmr.2.1.13]
41. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. [DOI:10.1001/jama.285.19.2486]
42. Charnvises K, Weerakiet S, Tingthanatikul Y, Wansumrith S, Chanprasertyothin S, Rojanasakul A. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2005; 21: 161-164. [DOI:10.1080/09513590500216776]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb